NDRA short interest
ENDRA Life Sciences Inc. · Healthcare · Medical - Diagnostics & Research · settlement date 2026-09-30
| Shares short | 28,233 |
|---|---|
| Change vs prior report | -3,107 (-9.9%) |
| Change over six months | -46.4% |
| Days to cover | 1.00 (sector: 3.78) |
| Average daily volume | 49,307 |
| Rank in Healthcare | not ranked (OTC, fund or thinly traded) |
NDRA short interest, last 12 months
| Settlement | Shares short | Change | Days to cover | Avg daily volume |
|---|---|---|---|---|
| 2026-09-30 | 28,233 | -9.9% | 1.00 | 49,307 |
| 2026-09-15 | 31,340 | -0.9% | 1.00 | 78,974 |
| 2026-08-31 | 31,615 | +5.1% | 2.46 | 12,876 |
| 2026-08-14 | 30,078 | -8.7% | 1.77 | 16,996 |
| 2026-07-31 | 32,947 | +19.2% | 1.74 | 18,914 |
| 2026-07-15 | 27,635 | -34.4% | 1.00 | 36,764 |
| 2026-06-30 | 42,119 | +92.3% | 1.00 | 81,330 |
| 2026-06-15 | 21,904 | +10.5% | 1.48 | 14,810 |
| 2026-05-29 | 19,820 | -39.2% | 1.10 | 18,084 |
| 2026-05-15 | 32,603 | -11.8% | 2.08 | 15,696 |
| 2026-04-30 | 36,954 | -23.5% | 1.72 | 21,491 |
| 2026-04-15 | 48,279 | -8.4% | 2.81 | 17,179 |
| 2026-03-31 | 52,702 | -2.2% | 1.19 | 44,448 |
| 2026-03-13 | 53,910 | -65.2% | 1.00 | 86,029 |
| 2026-02-27 | 154,773 | +163.6% | 1.00 | 511,270 |
| 2026-02-13 | 58,719 | +27.0% | 2.52 | 23,319 |
| 2026-01-30 | 46,244 | -6.3% | 1.56 | 29,584 |
| 2026-01-15 | 49,378 | -15.3% | 3.25 | 15,186 |
| 2025-12-31 | 58,311 | -25.3% | 3.21 | 18,189 |
| 2025-12-15 | 78,064 | -7.3% | 1.00 | 131,567 |
| 2025-11-28 | 84,183 | -16.1% | 1.00 | 91,881 |
| 2025-11-14 | 100,283 | +12.7% | 2.22 | 45,097 |
| 2025-10-31 | 89,024 | -8.2% | 1.00 | 120,903 |
| 2025-10-15 | 96,975 | -1.6% | 1.00 | 1,325,189 |
| 2025-09-30 | 98,587 | -6.6% | 2.98 | 33,036 |
import finzdata as yf
yf.Ticker("NDRA").short_interest # every report since 2017
yf.Client().short_interest(["NDRA"], start="2018-01-01")Healthcare short interest · NDRA price history · Who owns NDRA · All short interest